CMS-HCC Disease Coefficient |
Risk Adjustment Search Tool HCC Category Demographic Coefficient Back to HCC Risk Adjustment |
The table below shows HCC coefficients for the HCCs defined in the risk adjustment model in the specified payment year. CMS-HCC risk adjustment models are applied to the community non-dual aged, community non-dual disabled, community full benefit dual aged, community full benefit dual disabled, community partial benefit dual aged, community partial benefit dual disabled, and institutional.
HCC Category Description | Community, NonDual, Aged | Community, NonDual, Disabled | Community, FBDual, Aged | Community, FBDual, Disabled | Community, PBDual, Aged | Community, PBDual, Disabled | Institutional | |
---|---|---|---|---|---|---|---|---|
1 | HIV/AIDS | 0.301 | 0.213 | 0.397 | 0.237 | 0.196 | 0.109 | 1.322 |
2 | Septicemia, Sepsis, Systemic Inflammatory Response Syndrome/Shock | 0.500 | 0.598 | 0.649 | 0.780 | 0.447 | 0.591 | 0.605 |
6 | Opportunistic Infections | 0.381 | 0.763 | 0.588 | 0.833 | 0.518 | 0.685 | 0.728 |
17 | Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic | 4.209 | 3.995 | 3.896 | 4.235 | 3.946 | 4.103 | 1.952 |
18 | Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid | 2.341 | 2.486 | 2.277 | 2.537 | 2.166 | 2.403 | 1.110 |
19 | Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers | 1.798 | 1.989 | 1.563 | 1.661 | 1.520 | 1.554 | 0.957 |
20 | Lung and Other Severe Cancers | 1.136 | 0.978 | 1.166 | 1.173 | 1.214 | 1.067 | 0.672 |
21 | Lymphoma and Other Cancers | 0.671 | 0.540 | 0.654 | 0.739 | 0.627 | 0.618 | 0.493 |
22 | Bladder, Colorectal, and Other Cancers | 0.363 | 0.366 | 0.382 | 0.409 | 0.410 | 0.351 | 0.314 |
23 | Prostate, Breast, and Other Cancers and Tumors | 0.186 | 0.233 | 0.196 | 0.218 | 0.203 | 0.237 | 0.197 |
35 | Pancreas Transplant Status | 0.949 | 1.393 | 1.117 | 0.573 | 1.117 | 2.740 | 1.106 |
36 | Diabetes with Severe Acute Complications | 0.166 | 0.191 | 0.186 | 0.235 | 0.166 | 0.210 | 0.280 |
37 | Diabetes with Chronic Complications | 0.166 | 0.191 | 0.186 | 0.235 | 0.166 | 0.210 | 0.280 |
38 | Diabetes with Glycemic, Unspecified, or No Complications | 0.166 | 0.191 | 0.186 | 0.235 | 0.166 | 0.210 | 0.280 |
48 | Morbid Obesity | 0.186 | 0.144 | 0.300 | 0.178 | 0.164 | 0.118 | 0.442 |
49 | Specified Lysosomal Storage Disorders | 9.256 | 13.778 | 2.833 | 6.399 | 3.269 | 7.771 | 1.528 |
50 | Amyloidosis, Porphyria, and Other Specified Metabolic Disorders | 0.648 | 0.883 | 0.555 | 0.789 | 0.435 | 0.529 | 0.362 |
51 | Addison's and Cushing's Diseases, Acromegaly, and Other Specified Endocrine Disorders | 0.510 | 0.606 | 0.634 | 0.654 | 0.313 | 0.393 | 0.620 |
62 | Liver Transplant Status/Complications | 0.376 | 0.184 | 0.261 | 0.409 | 0.571 | 0.271 | 0.593 |
63 | Chronic Liver Failure/End-Stage Liver Disorders | 0.962 | 1.032 | 1.102 | 1.209 | 0.861 | 1.101 | 0.894 |
64 | Cirrhosis of Liver | 0.447 | 0.383 | 0.475 | 0.414 | 0.391 | 0.270 | 0.378 |
65 | Chronic Hepatitis | 0.185 | 0.248 | 0.101 | 0.220 | 0.156 | 0.189 | 0.378 |
68 | Cholangitis and Obstruction of Bile Duct Without Gallstones | 0.388 | 0.383 | 0.085 | 0.354 | 0.391 | 0.270 | 0.090 |
77 | Intestine Transplant Status/Complications | 1.172 | 6.301 | 5.039 | 6.161 | 5.039 | 5.039 | 5.089 |
78 | Intestinal Obstruction/Perforation | 0.326 | 0.534 | 0.382 | 0.548 | 0.478 | 0.688 | 0.380 |
79 | Chronic Pancreatitis | 0.357 | 0.574 | 0.525 | 0.799 | 0.444 | 0.709 | 0.218 |
80 | Crohn's Disease (Regional Enteritis) | 0.550 | 0.635 | 0.490 | 0.651 | 0.479 | 0.603 | 0.374 |
81 | Ulcerative Colitis | 0.244 | 0.285 | 0.201 | 0.286 | 0.205 | 0.237 | 0.258 |
92 | Bone/Joint/Muscle/Severe Soft Tissue Infections/Necrosis | 0.479 | 0.529 | 0.611 | 0.632 | 0.471 | 0.539 | 0.556 |
93 | Rheumatoid Arthritis and Other Specified Inflammatory Rheumatic Disorders | 0.617 | 0.470 | 0.439 | 0.384 | 0.405 | 0.288 | 0.297 |
94 | Systemic Lupus Erythematosus and Other Specified Systemic Connective Tissue Disorders | 0.268 | 0.239 | 0.237 | 0.250 | 0.224 | 0.196 | 0.297 |
107 | Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero | 0.457 | 1.449 | 0.610 | 1.939 | 0.303 | 1.569 | 0.692 |
108 | Sickle Cell Disorders, Except Sickle Cell Anemia (Hb-SS) and Thalassemia Beta Zero; Beta Thalassemia Major | 0.146 | 0.386 | 0.103 | 0.408 | 0.303 | 0.416 | 0.098 |
109 | Acquired Hemolytic, Aplastic, and Sideroblastic Anemias | 1.144 | 1.815 | 1.048 | 1.541 | 1.009 | 1.514 | 0.529 |
111 | Hemophilia, Male | 4.639 | 30.706 | 15.539 | 31.424 | 11.201 | 32.199 | 6.310 |
112 | Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions | 0.450 | 0.640 | 0.460 | 0.634 | 0.574 | 0.708 | 0.516 |
114 | Common Variable and Combined Immunodeficiencies | 2.262 | 2.598 | 2.016 | 2.670 | 2.137 | 2.789 | 0.691 |
115 | Specified Immunodeficiencies and White Blood Cell Disorders | 0.565 | 0.692 | 0.438 | 0.498 | 0.302 | 0.613 | 0.691 |
125 | Dementia, Severe | 0.341 | 0.296 | 0.438 | 0.367 | 0.401 | 0.345 | 0.000 |
126 | Dementia, Moderate | 0.341 | 0.296 | 0.438 | 0.367 | 0.401 | 0.345 | 0.000 |
127 | Dementia, Mild or Unspecified | 0.341 | 0.296 | 0.438 | 0.367 | 0.401 | 0.345 | 0.000 |
135 | Drug Use with Psychotic Complications | 0.424 | 0.637 | 0.702 | 1.181 | 0.522 | 0.922 | 0.297 |
136 | Alcohol Use with Psychotic Complications | 0.424 | 0.637 | 0.502 | 1.181 | 0.522 | 0.922 | 0.297 |
137 | Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications | 0.424 | 0.365 | 0.502 | 0.471 | 0.394 | 0.348 | 0.297 |
138 | Drug Use Disorder, Mild, Uncomplicated, Except Cannabis | 0.423 | 0.264 | 0.502 | 0.384 | 0.355 | 0.348 | 0.297 |
139 | Alcohol Use Disorder, Moderate/Severe, or Alcohol Use with Specified Non-Psychotic Complications | 0.242 | 0.207 | 0.478 | 0.250 | 0.308 | 0.159 | 0.000 |
151 | Schizophrenia | 0.511 | 0.380 | 0.591 | 0.414 | 0.501 | 0.304 | 0.449 |
152 | Psychosis, Except Schizophrenia | 0.484 | 0.290 | 0.579 | 0.255 | 0.501 | 0.247 | 0.208 |
153 | Personality Disorders; Anorexia/Bulimia Nervosa | 0.396 | 0.290 | 0.420 | 0.255 | 0.464 | 0.232 | 0.199 |
154 | Bipolar Disorders without Psychosis | 0.351 | 0.166 | 0.349 | 0.126 | 0.314 | 0.108 | 0.199 |
155 | Major Depression, Moderate or Severe, without Psychosis | 0.299 | 0.166 | 0.316 | 0.126 | 0.269 | 0.108 | 0.199 |
180 | Quadriplegia | 1.125 | 0.986 | 1.068 | 1.095 | 1.311 | 1.399 | 0.735 |
181 | Paraplegia | 0.942 | 0.648 | 0.859 | 0.832 | 0.883 | 0.852 | 0.563 |
182 | Spinal Cord Disorders/Injuries | 0.478 | 0.368 | 0.402 | 0.308 | 0.401 | 0.316 | 0.270 |
190 | Amyotrophic Lateral Sclerosis and Other Motor Neuron Disease, Spinal Muscular Atrophy | 1.175 | 1.792 | 1.427 | 3.642 | 0.640 | 1.243 | 0.628 |
191 | Quadriplegic Cerebral Palsy | 0.855 | 0.743 | 0.393 | 0.466 | 0.840 | 0.104 | 0.000 |
192 | Cerebral Palsy, Except Quadriplegic | 0.314 | 0.129 | 0.000 | 0.067 | 0.220 | 0.104 | 0.000 |
193 | Chronic Inflammatory Demyelinating Polyneuritis and Multifocal Motor Neuropathy | 1.692 | 1.427 | 0.957 | 0.939 | 1.149 | 0.850 | 0.913 |
195 | Myasthenia Gravis with (Acute) Exacerbation | 2.909 | 3.633 | 2.153 | 3.323 | 2.690 | 1.779 | 1.837 |
196 | Myasthenia Gravis without (Acute) Exacerbation and Other Myoneural Disorders | 0.516 | 0.642 | 0.503 | 0.507 | 0.427 | 0.248 | 0.486 |
197 | Muscular Dystrophy | 0.426 | 0.632 | 0.369 | 0.681 | 0.162 | 0.145 | 0.292 |
198 | Multiple Sclerosis | 0.647 | 0.908 | 0.791 | 1.143 | 0.569 | 0.770 | 0.226 |
199 | Parkinson and Other Degenerative Disease of Basal Ganglia | 0.615 | 0.517 | 0.634 | 0.504 | 0.474 | 0.354 | 0.219 |
200 | Friedreich and Other Hereditary Ataxias; Huntington Disease | 0.279 | 0.208 | 0.165 | 0.281 | 0.050 | 0.428 | 0.000 |
201 | Seizure Disorders and Convulsions | 0.245 | 0.196 | 0.233 | 0.170 | 0.245 | 0.202 | 0.131 |
202 | Coma, Brain Compression/Anoxic Damage | 0.543 | 0.238 | 0.721 | 0.279 | 0.549 | 0.309 | 0.097 |
211 | Respirator Dependence/Tracheostomy Status/Complications | 0.879 | 0.878 | 1.981 | 1.418 | 1.022 | 0.590 | 1.570 |
212 | Respiratory Arrest | 0.370 | 0.510 | 0.573 | 0.662 | 0.409 | 0.493 | 0.258 |
213 | Cardio-Respiratory Failure and Shock | 0.370 | 0.510 | 0.573 | 0.662 | 0.409 | 0.493 | 0.258 |
221 | Heart Transplant Status/Complications | 1.053 | 0.999 | 1.412 | 1.781 | 0.880 | 1.371 | 0.840 |
222 | End-Stage Heart Failure | 2.505 | 5.770 | 2.927 | 6.612 | 3.009 | 6.106 | 0.826 |
223 | Heart Failure with Heart Assist Device/Artificial Heart | 2.505 | 5.770 | 2.927 | 6.612 | 3.009 | 6.106 | 0.826 |
224 | Acute on Chronic Heart Failure | 0.360 | 0.442 | 0.406 | 0.537 | 0.311 | 0.411 | 0.217 |
225 | Acute Heart Failure (Excludes Acute on Chronic) | 0.360 | 0.442 | 0.406 | 0.537 | 0.311 | 0.411 | 0.217 |
226 | Heart Failure, Except End-Stage and Acute | 0.360 | 0.442 | 0.406 | 0.537 | 0.311 | 0.411 | 0.217 |
227 | Cardiomyopathy/Myocarditis | 0.189 | 0.200 | 0.173 | 0.198 | 0.145 | 0.186 | 0.189 |
228 | Acute Myocardial Infarction | 0.252 | 0.254 | 0.493 | 0.517 | 0.324 | 0.407 | 0.310 |
229 | Unstable Angina and Other Acute Ischemic Heart Disease | 0.240 | 0.254 | 0.325 | 0.458 | 0.278 | 0.315 | 0.310 |
238 | Specified Heart Arrhythmias | 0.299 | 0.296 | 0.407 | 0.304 | 0.293 | 0.261 | 0.245 |
248 | Intracranial Hemorrhage | 0.239 | 0.180 | 0.377 | 0.332 | 0.313 | 0.183 | 0.081 |
249 | Ischemic or Unspecified Stroke | 0.239 | 0.180 | 0.377 | 0.277 | 0.299 | 0.172 | 0.081 |
253 | Hemiplegia/Hemiparesis | 0.387 | 0.320 | 0.437 | 0.390 | 0.437 | 0.403 | 0.000 |
254 | Monoplegia, Other Paralytic Syndromes | 0.321 | 0.172 | 0.292 | 0.365 | 0.290 | 0.335 | 0.000 |
263 | Atherosclerosis of Arteries of the Extremities with Ulceration or Gangrene | 1.118 | 1.066 | 1.432 | 1.276 | 1.007 | 1.056 | 0.696 |
264 | Vascular Disease with Complications | 0.455 | 0.520 | 0.498 | 0.461 | 0.513 | 0.622 | 0.338 |
267 | Deep Vein Thrombosis and Pulmonary Embolism | 0.294 | 0.431 | 0.445 | 0.568 | 0.338 | 0.498 | 0.245 |
276 | Lung Transplant Status/Complications | 2.531 | 1.583 | 2.210 | 2.292 | 2.961 | 1.277 | 3.085 |
277 | Cystic Fibrosis | 0.998 | 2.818 | 1.340 | 3.760 | 0.650 | 3.829 | 0.873 |
278 | Idiopathic Pulmonary Fibrosis and Lung Involvement in Systemic Sclerosis | 0.818 | 1.209 | 0.791 | 1.640 | 0.650 | 0.937 | 0.873 |
279 | Severe Persistent Asthma | 0.818 | 0.842 | 0.594 | 0.808 | 0.650 | 0.804 | 0.873 |
280 | Chronic Obstructive Pulmonary Disease, Interstitial Lung Disorders, and Other Chronic Lung Disorders | 0.319 | 0.209 | 0.390 | 0.281 | 0.321 | 0.234 | 0.312 |
282 | Aspiration and Specified Bacterial Pneumonias | 0.440 | 0.362 | 0.538 | 0.269 | 0.409 | 0.173 | 0.353 |
283 | Empyema, Lung Abscess | 0.204 | 0.000 | 0.131 | 0.074 | 0.000 | 0.000 | 0.000 |
298 | Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage | 0.336 | 0.364 | 0.323 | 0.319 | 0.327 | 0.301 | 0.545 |
300 | Exudative Macular Degeneration | 0.596 | 0.366 | 0.370 | 0.255 | 0.459 | 0.380 | 0.196 |
326 | Chronic Kidney Disease, Stage 5 | 0.815 | 0.927 | 0.985 | 0.946 | 0.965 | 1.050 | 0.958 |
327 | Chronic Kidney Disease, Severe (Stage 4) | 0.514 | 0.523 | 0.565 | 0.661 | 0.484 | 0.447 | 0.462 |
328 | Chronic Kidney Disease, Moderate (Stage 3B) | 0.127 | 0.179 | 0.116 | 0.181 | 0.140 | 0.178 | 0.145 |
329 | Chronic Kidney Disease, Moderate (Stage 3, Except 3B) | 0.127 | 0.179 | 0.116 | 0.181 | 0.140 | 0.178 | 0.145 |
379 | Pressure Ulcer of Skin with Necrosis Through to Muscle, Tendon, or Bone | 1.965 | 2.140 | 2.580 | 2.570 | 2.349 | 2.349 | 1.420 |
380 | Chronic Ulcer of Skin, Except Pressure, Through to Bone or Muscle | 1.078 | 1.091 | 1.422 | 1.285 | 1.268 | 1.378 | 0.839 |
381 | Pressure Ulcer of Skin with Full Thickness Skin Loss | 1.075 | 1.091 | 1.379 | 1.192 | 1.136 | 1.089 | 0.423 |
382 | Pressure Ulcer of Skin with Partial Thickness Skin Loss | 0.838 | 0.994 | 1.029 | 0.935 | 0.845 | 0.937 | 0.343 |
383 | Chronic Ulcer of Skin, Except Pressure, Not Specified as Through to Bone or Muscle | 0.646 | 0.707 | 0.890 | 0.707 | 0.660 | 0.654 | 0.343 |
385 | Severe Skin Burn | 1.291 | 0.234 | 2.362 | 0.857 | 0.000 | 0.204 | 0.000 |
387 | Pemphigus, Pemphigoid, and Other Specified Autoimmune Skin Disorders | 0.406 | 0.302 | 0.658 | 0.622 | 0.477 | 0.498 | 0.125 |
397 | Major Head Injury with Loss of Consciousness > 1 Hour | 0.199 | 0.150 | 0.349 | 0.190 | 0.128 | 0.052 | 0.085 |
398 | Major Head Injury with Loss of Consciousness < 1 Hour or Unspecified | 0.199 | 0.150 | 0.349 | 0.190 | 0.128 | 0.052 | 0.085 |
399 | Major Head Injury without Loss of Consciousness | 0.199 | 0.150 | 0.349 | 0.190 | 0.128 | 0.052 | 0.085 |
401 | Vertebral Fractures without Spinal Cord Injury | 0.522 | 0.605 | 0.622 | 0.559 | 0.538 | 0.412 | 0.231 |
402 | Hip Fracture/Dislocation | 0.467 | 0.561 | 0.561 | 0.570 | 0.499 | 0.527 | 0.089 |
405 | Traumatic Amputations and Complications | 0.598 | 0.577 | 0.799 | 0.844 | 0.639 | 0.698 | 0.284 |
409 | Amputation Status, Lower Limb/Amputation Complications | 0.598 | 0.562 | 0.799 | 0.844 | 0.604 | 0.623 | 0.284 |
454 | Stem Cell, Including Bone Marrow, Transplant Status/Complications | 1.068 | 0.452 | 1.326 | 0.608 | 1.338 | 0.416 | 1.596 |
463 | Artificial Openings for Feeding or Elimination | 0.673 | 0.914 | 0.891 | 0.947 | 0.526 | 0.853 | 0.634 |
Risk Adjustment Search Tool | HCC Category | Demographic Coefficient | Back to HCC Risk Adjustment